Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Dec 27;20(10):2327–2336.e4. doi: 10.1016/j.cgh.2021.12.033

Table 2.

Cross-sectional Imaging Features Association With Endoscopic POR

Factor Overall (N = 216) No POR (n = 132) Endoscopic POR (n = 84) P-value
N Statistics
Time from start time-point to matched endoscopy, d 216 709.5 [351.5–1329.25] 680.5 [297.95–1294.5] 805 [429.75–1353.75] .15a
Active disease sites proximal to neoTI 216 40 (18.5) 22 (16.7) 18 (21.4) .49b
Disease presence relative to neoTI, cm 216 .003c
No disease 47 (21.8) 38 (28.8) 9 (10.7)
0–5 163 (75.5) 91 (68.9) 72 (85.7)
5–10 3 (1.4) 0 (0.00) 3 (3.6)
10–20 1 (0.46) 1 (0.76) 0 (0.00)
>20 cm 2 (0.93) 2 (1.5) 0 (0.00)
Intestinal wall thickening 215 165 (76.7) 90 (68.7) 75 (89.3) .001b
Luminal narrowing 216 130 (60.2) 70 (53.0) 60 (71.4) .011b
Hyper-enhancement 216 158 (73.1) 86 (65.2) 72 (85.7) .002b
Length of disease, cm 216 < .001b
No disease 46 (21.3) 37 (28.0) 9 (10.7)
1–10 114 (52.8) 73 (55.3) 41 (48.8)
>10 56 (25.9) 22 (16.6) 34 (40.4)
Upstream stasis >2.5 cm 207 14 (6.8) 9 (7.1) 5 (6.2) .99b
Upstream dilation >3 cm 214 90 (42.1) 43 (32.8) 47 (56.6) .001b
Mural fat 213 37 (17.4) 23 (17.6) 14 (17.1) .99b
Pseudosacculations 214 13 (6.1) 10 (7.6) 3 (3.6) .37b
Fibrofatty proliferation 212 43 (20.3) 22 (16.8) 21 (25.9) .15b
Penetrating disease 215 10 (4.7) 1 (0.76) 9 (10.8) .008c
Graded radiologic severity 216 < .001c
No 51 (23.6) 42 (31.8) 9 (10.7)
Minimal 48 (22.2) 38 (28.8) 10 (11.9)
Mild 70 (32.4) 35 (26.5) 35 (41.7)
Moderate 39 (18.1) 14 (10.6) 25 (29.8)
Severe 8 (3.7) 3 (2.3) 5 (6.0)
Any radiologic activity 216 165 (76.4) 90 (68.2) 75 (89.3) .001b

Note: Data are presented as median [IQR] or number (%).

Note: Boldface P-values indicate statistical significance.

IQR, Interquartile range; neoTI, neoterminal ileum; POR, postoperative recurrence.

a

P-values: Kruskal-Wallis test.

b

P-values: Pearson χ2 test.

c

P-values: Fisher exact test.